P31947 (1433S_HUMAN) Homo sapiens (Human)

14-3-3 protein sigma UniProtKBInterProSTRINGInteractive Modelling

248 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Pan troglodytes: A0A6D2X694; H2RC87; Pan paniscus: A0A2R8ZKA8; Gorilla gorilla gorilla: G3R777; Nomascus leucogenys: G1SAD1

Sequence Features

Add
 56Interaction with phosphoserine on interacting protein
 129Interaction with phosphoserine on interacting protein
 155M -> I (in dbSNP:rs11542705) VAR_048095 dbSNP
 9-23114-3-3 domain
IPR023410PF00244

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) Heteromer
P04049;
CL;MG;3iqu1-231
Assess
14-3-3 sigma in complex with IkappaBalpha pS63 peptide Heteromer
P25963;
CA;CL;MG; 14×GOL;6y1j1-231
Assess
14-3-3sigma in complex with a P129beta3P mutated YAP pS127 phosphopeptide Heteromer
P46937;
CL;NA;6g6x1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 in complex with DP005 Heteromer
Q04206;
CL;0V4;6nv21-231
Assess
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (10mer) Heteromer
P04049;
CL;MG;3iqj1-231
Assess
14-3-3 sigma in complex with YAP pS127-peptide Heteromer
P46937;
MG;CL;CA;GOL;3mhr1-231
Assess
Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide Heteromer
P03372;
7nfw1-231
Assess
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) and stabilisator Fusico… Heteromer
P04049;
FSC;CL;MG;3iqv1-231
Assess
Fragment AZ-003 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
MG;CL;K48;6rhc1-231
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide Heteromer
P04637;
CA;MG;5mhc1-231
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C45 mutant bound to disulfide f… Heteromer
P03372;
MG;GE8;6hmu1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 Heteromer
Q04206;
GOL;6qhl1-231
Assess
14-3-3 sigma bound to bis-phosphorylated aminopeptidase N (APN, CD13) via canonical and non-canonic… Heteromer
P15144;
NA;CL;7aew1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521 Heteromer
Q04206;
L3Y;6yow1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS281 Heteromer
Q04206;
6qhm1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2e-I with 14-3-3sigma Heteromer
P10636;
NA;D3W;CL;6fau1-231
Assess
14-3-3sigma in complex with a S131beta3S mutated YAP pS127 phosphopeptide Heteromer
P46937;
CL;MG;NA;6g8k1-231
Assess
Fragment AZ-018 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
K5Z;6rjl1-231
Assess
Binary complex of 14-3-3 sigma and p53 pT387-peptide Heteromer
P04637;
MG;CL;GOL;3lw11-231
Assess
Fragment AZ-003 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;K48;6rl31-231
Assess
Crystal structure of 14-3-3 sigma in complex with wild-type Shroom3 Heteromer
Q8TF72;
MG;CL;6fbb1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935 Heteromer
Q5S007;
CA;CL;5my91-231
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV3 Heteromer
Q9GZV5;
MG;CL;CA;8OE;5n5w1-231
Assess
14-3-3sigma in complex with a L132beta3L mutated YAP pS127 phosphopeptide Heteromer
P46937;
CL;MG;NA;6g8l1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2c-I with 14-3-3sigma Heteromer
P10636;
CL;MG;NA;D3K;6faw1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-I with 14-3-3sigma Heteromer
P10636;
NA;D3Q;CL;6fav1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 126B with 14-3-3sigma Heteromer
P10636;
CL;4y5i1-231
Assess
Structure of 14-3-3 sigma in complex with PADI6 14-3-3 binding motif II Heteromer
Q6TGC4;
MG;4dat1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide Heteromer
Q9NPC2;
MG;CL;3p1n1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-123 Heteromer
Q04206;
P7E;6ypy1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-129 Heteromer
Q04206;
P7T;6yq21-231
Assess
14-3-3 Sigma in complex with phosphorylated MLF1 peptide Heteromer
P58340;
CA;MG;CL;6y8e1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-II with 14-3-3sigma Heteromer
P10636;
CL;NA;D4K;6fbw1-231
Assess
A novel phospho-switch in the linker region of the snail zinc finger protein which regulates 14-3-3… Heteromer
O95863;
MG;GOL;4qli1-231
Assess
Crystal structure of 14-3-3 sigma in complex with Shroom3 P1244L Heteromer
Q8TF72;
MG;CL;6fcp1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910 Heteromer
Q5S007;
CA;CL;NA;5myc1-231
Assess
Fragment AZ-010 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
KM8;6rwu1-231
Assess
14-3-3sigma in complex with a A130beta3A mutated YAP pS127 phosphopeptide Heteromer
P46937;
CL;MG;NA;B3A;6g8j1-231
Assess
14-3-3 Sigma in complex with phosphorylated c-Jun peptide Heteromer
P05412;
MG;CA;6y3v1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 4.2b with 14-3-3sigma Heteromer
P10636;
CL;NA;D4H;6fby1-231
Assess
14-3-3 Sigma in complex with phosphorylated camkk2{pS511} peptide Heteromer
Q96RR4;
MG;CL;6y8a1-231
Assess
14-3-3 Sigma in complex with phosphorylated CAMKK2 peptide Heteromer
Q96RR4;
MG;CA;6y3o1-231
Assess
14-3-3 Sigma in complex with phosphorylated (Thr391) Gab2 peptide Heteromer
Q9UQC2;
MG;6y3r1-231
Assess
14-3-3 Sigma in complex with phosphorylated caspase{pS164} peptide Heteromer
P42575;
MG;CL;6y8d1-231
Assess
Fragment AZ-009 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
KLZ;MG;6rws1-231
Assess
14-3-3 Sigma in complex with phosphorylated caspase{pS139} peptide Heteromer
P42575;
MG;CL;6y8b1-231
Assess
Fragment AZ-015 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;K6B;6rjz1-231
Assess
14-3-3sigma in complex with a R124beta3R mutated YAP pS127 phosphopeptide Heteromer
P46937;
CL;MG;NA;6g8i1-231
Assess
Fragment AZ-024 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K7Q;6rl61-231
Assess
Fragment AZ-025 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K7N;6rl41-231
Assess
Fragment AZ-026 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K92;6rm71-231
Assess
Fragment AZ-011 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;LFB;6sip1-231
Assess
Fragment AZ-012 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
CL;LF5;6siq1-231
Assess
Fragment AZ-014 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K6N;6rk81-231
Assess
Fragment AZ-017 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;LFQ;6sio1-231
Assess
Crystal structure of 14-3-3sigma in complex with a PAK6 pT99 phosphopeptide Heteromer
Q9NQU5;
CA;CL;MG;NA;6qdr1-231
Assess
Fragment AZ-020 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
K65;6sin1-231
Assess
Fragment AZ-002 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
KLE;CA;MG;6rwi1-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide and stabilizer fu… Heteromer
Q9NPC2;
FSC;CL;MG;3p1s1-231
Assess
Fragment AZ-007 binding at a primary and secondary binding site of the the p53pT387/14-3-3 sigma co… Heteromer
P04637;
KLB;CA;MG;6rwh1-231
Assess
Fragment AZ-004 binding at a primary and secondary site in a p53pT387/14-3-3 complex Heteromer
P04637;
L1T;CA;6s9q1-231
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide Heteromer
Q9NPC2;
MG;CL;CA;3p1r1-231
Assess
14-3-3 isoform sigma in complex with a phosphorylated C-RAF peptide Heteromer
P04049;
4iea1-231
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… Heteromer
P03372;
MG;G8Q;6hkb1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2d with 14-3-3sigma Heteromer
P10636;
CL;MG;NA;60H;6fi51-231
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS324 Heteromer
P10636;
MG;CA;CL;5btv1-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 Peptide and stabilizer fu… Heteromer
Q9NPC2;
FSC;CL;MG;CA;3p1q1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 109B with 14-3-3sigma Heteromer
P10636;
49F;4y321-231
Assess
Crystal structure of 14-3-3sigma in complex with a RapGef2 pT740 phosphopeptide Heteromer
Q9Y4G8;
CA;CL; 10×NA;6qdt1-231
Assess
14-3-3 Sigma in complex with phosphorylated SOS1 peptide Heteromer
Q07889;
MG;CL;CA;6y441-231
Assess
Crystal structure of 14-3-3sigma in complex with a PAK6 pT99 phosphopeptide stabilized by semi-synt… Heteromer
Q9NQU5;
HY5;CL;NA;6qds1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilizer Fusicoccin H Heteromer
Q9NPC2;
MG;CL;GOL;0DV;3ux01-231
Assess
14-3-3 Sigma in complex with phosphorylated PLN peptide Heteromer
P26678;
MG;CL;6y401-231
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Fu… Heteromer
Q9NPC2;
FJA;MG;3smo1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma Heteromer
P10636;
49F;4y3b1-231
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Co… Heteromer
Q9NPC2;
CX7;MG;3sp51-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma Heteromer
P10636;
5hf31-231
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV2 Heteromer
Q9GZV5;
MG;CL;8OB;5n5t1-231
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide Heteromer
P04637;
CL;MG;5moc1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-037 Heteromer
Q04206;
CL;P6H;6ypl1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-028 Heteromer
Q04206;
CL;P5Q;6yp31-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-025 Heteromer
Q04206;
CL;L3S;6yoy1-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-033 Heteromer
Q04206;
CL;P6Z;6yp81-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-011 Heteromer
Q04206;
CL;P5N;6yp21-231
Assess
Fragment AZ-010 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
KM8;6slx1-231
Assess
14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV1 Heteromer
Q9GZV5;
MG;CL;NV1;5n5r1-231
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… Heteromer
P03372;
MG;G8T;6hkf1-231
Assess
Crystal structure of 14-3-3 sigma in complex with Ataxin-1 Ser776 phosphopeptide Heteromer
P54253;
MG;CL;6qiu1-231
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… Heteromer
P03372;
MG;G4Z;6hhp1-231
Assess
14-3-3 sigma in complex with TAZ pS89 peptide Heteromer
Q9GZV5;
MG;CL;5n751-231
Assess
Fragment AZ-005 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CA;KM2;6rx21-231
Assess
Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st… Heteromer
P03372;
MG;NE5;6tjm1-231
Assess
14-3-3sigma in complex with a A130beta3A and Q133beta3Q mutated YAP pS127 phosphopeptide Heteromer
P46937;
CA;CL;NA;6g8q1-231
Assess
Fragment AZ-021 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;K6W;6rkk1-231
Assess
Fragment AZ-022 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;K6Z;6rkm1-231
Assess
Fragment AZ-023 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K6T;6rki1-231
Assess
Fragment AZ-018 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
K5Z;CA;6s391-231
Assess
Fragment AZ-006 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;JT2;6r5l1-231
Assess
Fragment AZ-016 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;K8W;6rm51-231
Assess
Fragment AZ-019 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
KDK;CA;NA;6rp61-231
Assess
Fragment AZ-006 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
JT2;6rjq1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilizer 16-O-Me-FC-H Heteromer
Q9NPC2;
0V4;MG;4fr31-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide and stabilizer Fu… Heteromer
Q9NPC2;
FW1;CL;MG;3sml1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214 Heteromer
P10636;
CL;MG;CA;GOL;4fl51-231
Assess
Fragment AZ-001 binding at the p53pT387/14-3-3 sigma interface and additional sites Heteromer
P04637;
MG;CL;KTW;GOL;CA;6s401-231
Assess
Fragment AZ-013 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;LJW;6slv1-231
Assess
14-3-3sigma in complex with a P129beta3P and L132beta3L mutated YAP pS127 phosphopeptide Heteromer
P46937;
CA;CL;6g8p1-231
Assess
14-3-3 sigma in complex with FOXO1 pS256 peptide Heteromer
Q12778;
GOL;B3P;6qzs1-231
Assess
Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilisator Fusicoccin A Heteromer
Q9NPC2;
FSC;CL;CA;MG;3p1o1-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide Heteromer
Q9NPC2;
CL;MG;3p1p1-231
Assess
14-3-3sigma in complex with a TASK3 peptide stabilized by semi-synthetic natural product FC-NAc Heteromer
Q9NPC2;
EZ5;CL;NA;6ghp1-231
Assess
14-3-3 Sigma in complex with phosphorylated (pS210) Gab2 peptide Heteromer
Q9UQC2;
MG;6y3s1-231
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer FC… Heteromer
Q9NPC2;
FC7;CL;MG;3spr1-231
Assess
Fragment AZ-019 binding at the p53pT387/14-3-3 sigma interface Heteromer
P04637;
MG;CL;GOL;KDK;6s3c1-231
Assess
Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma Heteromer
P10636;
CA;CL;NA;60H;6fi41-231
Assess
Fragment AZ-004 binding at the TAZpS89/14-3-3 sigma interface Heteromer
Q9GZV5;
L1T;6slw1-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with task-3 peptide and stabilizer Fu… Heteromer
Q9NPC2;
FJA;MG;CL;3smm1-231
Assess
Structure of 14-3-3 sigma in complex with PADI6 14-3-3 binding motif I Heteromer
Q6TGC4;
4dau1-231
Assess
Structure of 14-3-3 isoform sigma in complex with a C-Raf1 peptide and a stabilizing small molecule… Heteromer
P04049;
M1T;3o8i1-231
Assess
Crystal structure of human 14-3-3 sigma C38N/N166H in complex with task-3 peptide and stabilizer Fu… Heteromer
Q9NPC2;
FC7;MG;CA;CL;3smn1-231
Assess
14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface Heteromer
P03372;
MG;4jc31-231
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-027 Heteromer
Q04206;
CL;L3V;CA;MG;6yox1-231
Assess
Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide and stabilizer Co… Heteromer
Q9NPC2;
CW7;MG;3smk1-231
Assess
14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface Heteromer
P03372;
FSC;4jdd1-231
Assess
14-3-3 sigma in complex with FOXO1 pT24 peptide Heteromer
Q12778;
B3P;GOL;6qzr1-231
Assess
Henipavirus W protein interacts with 14-3-3 to modulate host gene expression Heteromer
P0C1C7;
CA;6w0l1-231
Assess
Human 14-3-3 sigma CLU3 mutant complexed with short HSPB6 phosphopeptide Heteromer
O14558;
TRS;5lu11-231
Assess
Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st… Heteromer
P03372;
NJW;6tl31-231
Assess
CH2 chimera of human 14-3-3 sigma with the Gli1 phosphopeptide around Ser640 Heteromer
P08151;
SO4;TRS;5om01-231
Assess
CH3 chimera of human 14-3-3 sigma with the StARD1 peptide including Ser57 Heteromer
P49675;
TRS;SO4;5oma1-231
Assess
Complex of human 14-3-3 sigma CLU1 mutant with phosphorylated heat shock protein B6 Heteromer
O14558;
TRS;NI;5ltw1-231
Assess
Human 14-3-3 sigma complexed with long HSPB6 phosphopeptide Heteromer
O14558;
5lu22-231
Assess
CH1 chimera of human 14-3-3 sigma with the HSPB6 phosphopeptide in a conformation with swapped phos…homo-4-mer PEG;5ok91-231
Assess
The crystal structure of 14-3-3-sigma at 2.8 angstrom resolutionhomo-2-mer 1yz51-233
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…homo-2-mer MG;GEH;6hmt1-231
Assess
Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide stabilized by…homo-2-mer FSC;CL;MG;5mxo1-231
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…homo-2-mer MG;CL;O3W;6xxc1-231
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…homo-2-mer MG;CL;O68;6y181-231
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…homo-2-mer MG;CL;O4E;6xy51-231
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d…homo-2-mer MG;CL;O85;6y3w1-231
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (DBD) phosphopeptidehomo-2-mer MG;CL;6y1d1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 10×MG;CL;GOL;Y04;4dhr1-231
Assess
14-3-3 Sigma in complex with phosphorylated ATPase peptidehomo-2-mer MG;CA;6y3m1-231
Assess
14-3-3sigma in complex with SLP76pS376 phosphopeptide crystal structurehomo-2-mer 10×MG;6zcj1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 1CT;GOL;CL;MG;3t0l1-231
Assess
14-3-3 sigma bound to canonical mono-phosphorylated aminopeptidase N (APN, CD13) binding motifhomo-2-mer NA;CA;MG;6xwd1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 2CT;GOL;CL;MG;3t0m1-231
Assess
Crystal structure of 14-3-3sigma in complex with a RapGef2 pT740 phosphopeptide inhibited by semi-s…homo-2-mer HY5;TPO;CL;NA;6qdu1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 10×MG;CL;GOL;0KH;4dhu1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer MG;CL;GOL;Y09;4dho1-231
Assess
Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f…homo-2-mer MG;GF8;6hn21-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer MG;CL;GOL;0KB;4dhm1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer MG;CL;GOL;Y03;4dhs1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 10×MG;CL;GOL;Y06;4dhq1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer 10×MG;CL;GOL;Y07;4dhp1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer MG;CL;GOL;0KC;4dhn1-231
Assess
Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteinshomo-2-mer MG;CL;GOL;3u9x1-231
Assess
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screeninghomo-2-mer MG;CL;GOL;0KG;4dht1-231
Assess
Binary complex of 14-3-3 sigma and a high-affinity non-canonical 9-mer peptide binderhomo-2-mer MG;CL;6tch1-231
Assess
14-3-3sigma in complex with BLNKpT152 phosphopeptide crystal structurehomo-2-mer MG;6ylu1-231
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (LBD) phosphopeptidehomo-2-mer MG;6y581-231
Assess
Human 14-3-3 sigma fused to the StARD1 peptide including phosphoserine-57homo-2-mer PGE;IMD;6t5h1-231
Assess
Molecular tweezers modulate 14-3-3 protein-protein interactions.homo-2-mer 9SZ;CL;GOL;5oeh1-231
Assess
Ligand-free state of human 14-3-3 sigma isoformhomo-2-mer PEG; 12×SO4;6tlg1-231
Assess
Crystal structure of the human sigma isoform of 14-3-3 in complex with a mode-1 phosphopeptidehomo-2-mer CA;1ywt1-231
Assess
Human 14-3-3 sigma fused to the StARD1 peptide including phosphoserine-195homo-2-mer 6t5f1-231
Assess
14-3-3 sigma complexed with a phosphorylated 16E6 peptidehomo-2-mer TAR;6twz1-231
Assess
human 14-3-3 sigma isoform in complex with IMPhomo-2-mer IMP;SO4;6tlf1-231
Assess
Human 14-3-3 sigma fused to the AANAT peptide including phosphoserine-205homo-2-mer 6t801-231
Assess
Human 14-3-3 sigma isoform in complex with PLPhomo-2-mer PLP;SO4;6tm71-231
Assess
Molecular tweezers modulate 14-3-3 protein-protein interactionshomo-2-mer 9SZ;CL;5oeg1-231
Assess
CH1 chimera of human 14-3-3 sigma with the HSPB6 phosphopeptide in a conformation with self-bound p…homo-2-mer 11×CD;5okf1-231
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2homo-2-merPHE;-0.613lw1.1.B1-199
97.22
Assess